We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

Nicole Ryf President Kenosha Area Business Alliance 5500 6th Ave., Kenosha Employees: 7 kaba.org Nicole Ryf, president of the ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... appeared in an interview on Wealth at Yahoo Finance to share his market outlook, which happens to be rather ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as the drugmaker struggled to forecast demand for ...